BRN Discussion Ongoing

[Fullmoonfever]

Someone who's not behind a NDA appears to be ticking along and making some inroads with their development.

Multimodal AI and Neuromorphic AI: Detection, Diagnosis, Prognosis - Tata Elxsi

Discover how Multimodal and Neuromorphic AI lead healthcare from reactive to proactive. This article delves into Responsible AI and its transformative impact.

ai.tataelxsi.com

Tata Elxsi


MULTIMODAL AI AND NEUROMORPHIC AI: DETECTION, DIAGNOSIS, PROGNOSIS

Navigate​

The synergy of cutting-edge technologies like Multimodal and Neuromorphic AI signals a pivotal shift from reactive to proactive healthcare. This article explores captivating use cases, offering insights on the implementation of Responsible AI.
Join us as we navigate the frontier of healthcare, where the synergy of innovation and responsibility promises a revolution in patient care and well-being.

Current state of AI adoption in Healthcare​

Unlocking the full potential of AI in healthcare is an uncharted journey. From optimising drug combinations to spearheading clinical correlation and toxicity studies, AI is set to redefine every facet of the industry. Despite its transformative capabilities, AI remains a niche technology, requiring a nuanced understanding of its application in healthcare.
The tides are changing as the healthcare sector recognises the urgency for an interdisciplinary approach, marrying engineering with medical science. This paradigm shift signals an imminent era where AI’s vast capabilities will revolutionise diagnostics, patient treatment, protocols, drug development and delivery, and prescription practices over the next decade.
Join us as we navigate the frontier of healthcare, where the synergy of innovation and responsibility promises a revolution in patient care and well-being.

Multimodal AI and Neuromorphic Technology – A new era in Preventive Healthcare​

In the ever-evolving landscape of healthcare, the amalgamation of Multimodal AI and Neuromorphic Technology marks a pivotal moment—a shift from reactive medicine to a proactive, preventive healthcare paradigm. This synergy is not just a collaboration of cutting-edge technologies; it’s a gateway to a future where wellness takes centre stage.

These technologies hold promise to transform healthcare by enhancing diagnostics, enabling personalised medicine, predicting long-term prognosis and contributing to innovations in therapeutic interventions.
Let’s delve into compelling use cases and glimpse the future of preventive healthcare.
The tides are changing as the healthcare sector recognises the urgency for an interdisciplinary approach, marrying engineering with medical science. This paradigm shift signals an imminent era where AI’s vast capabilities will revolutionise diagnostics, patient treatment, protocols, drug development and delivery, and prescription practices over the next decade.
Join us as we navigate the frontier of healthcare, where the synergy of innovation and responsibility promises a revolution in patient care and well-being.

Defining Multimodal and Neuromorphic AI​

Multi-modal AI​

Multimodal AI refers to the artificial intelligence systems that process and analyse data from multiple modalities or sources. In healthcare, these modalities often include both visual and clinical data. Visual data may include medical images from scans, while clinical data encompasses patient records, parameters, and test reports. Multimodal AI integrates these diverse data types to provide a comprehensive understanding, draw meaningful insights and give suggestions based on data and image analytics.

Neuromorphic Technology​

The term “neuromorphic” comes from the combination of “neuro” (related to the nervous system) and “morphic” (related to form or structure). Neuromorphic technology is an innovative approach in computing that draws inspiration from the structure and function of a human brain. These are AI powered by brain-like computing architectures. It can help process larger amount of data with less computing power, memory and electric power consumption. Neuromorphic Technology utilises Artificial Neural Networks (ANN) and Spiking Neural Networks (SNN) to mimic the parallel processing, event-driven nature, and adaptability observed in biological brains.

Multimodal Inputs​

• Medical Images
• Lab Reports
• Clinical History
• Patient Demographic Information

Fusion Module​

Cross-modal attention mechanism to dynamically weigh the importance of text, video, and other parameters for calculating index to decide priority of selection.

Inference Outputs​

Inference Results for

• Diagnostic
• Prognostic
• Lifestyle Recommendation
• Disease Prediction

Use Cases of Multimodal and Neuromorphic AI​

Early Screening & Disease Detection​

Multimodal AI​

• Integrates visual and clinical data for holistic analysis.
• Advanced –image recognition for early detection.
• Comprehensive patient profiling.

Neuromorphic Technology​

• Efficient pattern recognition for subtle disease indicators.
• Event-driven processing for real-time detection. This is crucial for detecting anomalies or irregularities that may be early signs of diseases.
• Continuous monitoring for dynamic changes. This continuous surveillance is especially valuable for conditions with varying symptoms.

Diagnosis​

Multimodal AI​

• Integrated diagnostic insights from diverse data.
• Cross-verification for reliability.
• Tailored treatment plans based on nuanced understanding.
• Continuous updates based on latest findings reported in the subject.

Neuromorphic Technology​

• Large and Efficient data processing with minimal energy consumption. This efficiency contributes to faster and more accurate diagnoses.
• Allows integration of more complex algorithms on wearable devices; makes diagnostics more real-time and helps timely interventions
• Implantable devices can be made AI enabled with Neuromorphic computing, due to the low computing requirement and power consumption, making the diagnosis and management more precise and real-time.
• Adaptive intelligence for dynamic adjustments. This adaptability enhances the precision of diagnostic processes. This event-driven processing aligns with the dynamic nature of healthcare data allowing for more accurate and timely diagnoses.
• SNN for real-time response
  and accuracy.

Prognosis​

Multimodal AI​

• Research Advancements: Facilitates discovery of new insights, contributing to medical advancements and innovations.
• Personalised Prognostic Models: Considering both visual and clinical data, these models account for individual variations, and correlate with prior case records and provide more accurate predictions of disease outcomes.
• Dynamic Adaptability: The adaptability of multimodal AI to changing data patterns ensures that prognostic models can dynamically adjust based on evolving patient conditions and improve prognosis predictions

Neuromorphic Technology​

• Analysis of longitudinal data for predicting disease progression.
• Dynamic adaptability in prognostic models that can adjust to changing data patterns. This adaptability improves prognosis prediction accuracy for evolving patient conditions.
• Personalised prognostic insights based on individual variations can help in more accurate predictions tailored to individual patient profiles.

Tata Elxsi Use Case​

Disease Detection and Diagnosis​

Utilising Neuromorphic Technology, we’ve achieved significant advancements in the analysis of medical images on low-computing embedded platforms, enabling on-field diagnostics of ultrasound images.
This innovative approach provides critical diagnostic information for musculoskeletal injuries, including tissue damage extent, recovery progress, and healing time predictions, all with enhanced efficiency and device portability making it ideal for applications such as sports medicine.

Applications of Multimodal and Neuromorphic AI​

Multimodal AI​

• Comprehensive Patient Analysis
• Diagnostic Accuracy
• Mental Health and Behavioural Analysis
• Lifestyle Reviews and Recommendations
• Management of Chronic Diseases like Diabetes/HT/Cardiac Diseases with continous monitoring and personalised medications
• Diagnosis/Management and Prognosis of various types of cancers, Digital Drug Trials, Effective Pandemic Surveillance and staging, Gene Therapy and Genomics
• Recommendations for interventions and Prioritisation of therapeutic resources and modalities

Neuromorphic Technology​

• Implants, Wearables Devices
• Processing Large Data
• Medical Imaging Analysis
• Drug Discovery and Personalised Medicine
• Robotic Surgery Assistance
• Neurological Disorder Understanding
• Patient Care and Rehabilitation
• Predictive Analytics for Healthcare Management
• Energy Efficient Remote Monitoring

The Synergy of MLOps and Advanced AI​

The transformative impact of MLOps across operational efficiency, data management, patient outcomes, and the overall quality of care is unmistakable. In the quest for advancing healthcare, the convergence of Machine Learning Operations (MLOps) with Multimodal and Neuromorphic AI has emerged as a game-changer. These technologies can help in seamless deployment, continuous monitoring, and collaborative development across various stakeholders in the healthcare ecosystem.
While Advanced AI Technologies offer the potential for improvising the use cases, the application of MLOps can be instrumental in strengthening and regulating these advancements. It achieves this by bringing in streamlined AI development processes, dataset management, continuous monitoring of model accuracy across different versions, ensuring the deployment of thoroughly vetted versions for clinical use. Additonally, MLOps frameworks enable and learn from deviations, further enhancing their efficacy in healthcare applications.

Use Cases​

Disease Detection​

Disease Prediction and Prevention
Real World Application – Early Detection of Chronic Disease, Infectious Disease Monitoring
Healthcare Fraud Detection
Real World Application – Claims Analysis, Identify Theft Prevention
Medical Imaging Analysis
Real World Application – Early Cancer Detection, Neurological Disorders Diagnosis
Genomic Research
Real World Application – Cancer Genomics, Rare Genetic Diseases

Diagnosis​

Drug Discovery and Development
Real World Application – Protein Folding Prediction, Drug Toxicity Prediction
Personalised Medicine
Real World Application – Oncology and Targeted Therapies, Chronic Disease Management
Healthcare Resource Management
Real World Application – Emergency Room Digitalised Management, Pharmaceutical Supply Chain Management

Prognosis​

Prediction of Clinical Outcome
Real World Application – Prediction of recovery time and quality of life, Adverse Effects, Short term and long term impact
Remote Patient Monitoring
Real World Application – Chronic Disease Management, Post Surgery Monitoring

Responsible AI – Navigating Ethical Frontiers​

In the realm of AI, addressing bias stands as a pivotal ethical imperative, particularly in fields like medical analysis where the demand for precision is ethically, legally, and morally paramount. As AI practitioners, our commitment to responsible AI requires rigorous testing using diverse, unbiased anonymised datasets, continual monitoring to mitigate biases, and a steadfast dedication to achieving fair outcomes across diverse patient populations.

Moreover, the ethical considerations extend to the strategic utilisation of data. The foundation of responsible AI in healthcare is laid upon a robust ethical framework that guides the entire lifecycle of Neuromorphic and Multimodal AI systems. Stakeholders must unwaveringly adhere to established ethical principles, ensuring transparency, fairness, and accountability at every stage of AI implementation.
When we delve into the realm of Gen AI, the potential for malpractice looms. Consider scenarios where a patient, with normal renal function manageable through medication, undergoes a renal scan. Unscrupulous use of Gen AI could manipulate images, creating false lesions, leading to unnecessary surgeries or even nephrectomy which can benefit illegal organ trade
Thus, the imperative lies in defining strong ethical boundaries, implementing robust audits, and establishing legal frameworks to prevent data manipulation and ensure the highest standards of integrity.
In embracing these technological advancements responsibly, we are not just witnessing the future of healthcare; we are actively shaping it. The era of proactive, preventive healthcare beckons, promising a future where wellness is at the forefront of the industry’s evolution.
The shift from traditional, one-size-fits-all medical practices, prone to misinterpretation and diagnostic errors, to AI-enhanced methodologies, heralds a new era of precision and personalised care. AI’s capability to analyse a broad spectrum of patient data—ranging from genetic backgrounds to lifestyle factors—promises a departure from misdiagnoses and introduces tailored therapeutic interventions.
AI and multimodal technologies enable a holistic view of the patient’s health, integrating diverse data points. While, Neuromorphic computing advances the portability of medical devices, including wearables and implants, transforming them into intelligent systems capable of adapting to varying conditions.
As thought leaders in the healthcare industry, our commitment to responsibly integrate these technologies paves the way for a future where healthcare is not only reactive, but anticipatory, personalised, and universally accessible.

Author

Anup S S
Practice Head, Artificial Intelligence, Tata Elxsi
Anup S.S. is a visionary in leveraging Artificial Intelligence, Machine Learning and Deep Learning. Leading breakthrough AI projects in healthcare, Anup’s strategic insight and innovation ignite client success, unlocking AI’s full potential.

 

[Learning]

BrainChip on LinkedIn: Home

Catch BrainChip at the 2024 Embedded Vision Summit, May 21-24! Explore Akida's diverse applications. Don't miss our spotlight on the Akida Edge AI…

www.linkedin.com

Learning

 

[Quiltman]

NICE. Very NICE indeed !

 

[TECH]

Someone who's not behind a NDA appears to be tickling along and making some inroads with their development.

Multimodal AI and Neuromorphic AI: Detection, Diagnosis, Prognosis - Tata Elxsi

Discover how Multimodal and Neuromorphic AI lead healthcare from reactive to proactive. This article delves into Responsible AI and its transformative impact.

ai.tataelxsi.com

Tata Elxsi


MULTIMODAL AI AND NEUROMORPHIC AI: DETECTION, DIAGNOSIS, PROGNOSIS

Navigate​

The synergy of cutting-edge technologies like Multimodal and Neuromorphic AI signals a pivotal shift from reactive to proactive healthcare. This article explores captivating use cases, offering insights on the implementation of Responsible AI.
Join us as we navigate the frontier of healthcare, where the synergy of innovation and responsibility promises a revolution in patient care and well-being.

Current state of AI adoption in Healthcare​

Unlocking the full potential of AI in healthcare is an uncharted journey. From optimising drug combinations to spearheading clinical correlation and toxicity studies, AI is set to redefine every facet of the industry. Despite its transformative capabilities, AI remains a niche technology, requiring a nuanced understanding of its application in healthcare.
The tides are changing as the healthcare sector recognises the urgency for an interdisciplinary approach, marrying engineering with medical science. This paradigm shift signals an imminent era where AI’s vast capabilities will revolutionise diagnostics, patient treatment, protocols, drug development and delivery, and prescription practices over the next decade.
Join us as we navigate the frontier of healthcare, where the synergy of innovation and responsibility promises a revolution in patient care and well-being.

Multimodal AI and Neuromorphic Technology – A new era in Preventive Healthcare​

In the ever-evolving landscape of healthcare, the amalgamation of Multimodal AI and Neuromorphic Technology marks a pivotal moment—a shift from reactive medicine to a proactive, preventive healthcare paradigm. This synergy is not just a collaboration of cutting-edge technologies; it’s a gateway to a future where wellness takes centre stage.

These technologies hold promise to transform healthcare by enhancing diagnostics, enabling personalised medicine, predicting long-term prognosis and contributing to innovations in therapeutic interventions.
Let’s delve into compelling use cases and glimpse the future of preventive healthcare.
The tides are changing as the healthcare sector recognises the urgency for an interdisciplinary approach, marrying engineering with medical science. This paradigm shift signals an imminent era where AI’s vast capabilities will revolutionise diagnostics, patient treatment, protocols, drug development and delivery, and prescription practices over the next decade.
Join us as we navigate the frontier of healthcare, where the synergy of innovation and responsibility promises a revolution in patient care and well-being.

Defining Multimodal and Neuromorphic AI​

Multi-modal AI​

Multimodal AI refers to the artificial intelligence systems that process and analyse data from multiple modalities or sources. In healthcare, these modalities often include both visual and clinical data. Visual data may include medical images from scans, while clinical data encompasses patient records, parameters, and test reports. Multimodal AI integrates these diverse data types to provide a comprehensive understanding, draw meaningful insights and give suggestions based on data and image analytics.

Neuromorphic Technology​

The term “neuromorphic” comes from the combination of “neuro” (related to the nervous system) and “morphic” (related to form or structure). Neuromorphic technology is an innovative approach in computing that draws inspiration from the structure and function of a human brain. These are AI powered by brain-like computing architectures. It can help process larger amount of data with less computing power, memory and electric power consumption. Neuromorphic Technology utilises Artificial Neural Networks (ANN) and Spiking Neural Networks (SNN) to mimic the parallel processing, event-driven nature, and adaptability observed in biological brains.

Multimodal Inputs​

• Medical Images
• Lab Reports
• Clinical History
• Patient Demographic Information

Fusion Module​

Cross-modal attention mechanism to dynamically weigh the importance of text, video, and other parameters for calculating index to decide priority of selection.

Inference Outputs​

Inference Results for

• Diagnostic
• Prognostic
• Lifestyle Recommendation
• Disease Prediction

Use Cases of Multimodal and Neuromorphic AI​

Early Screening & Disease Detection​

Multimodal AI​

• Integrates visual and clinical data for holistic analysis.
• Advanced –image recognition for early detection.
• Comprehensive patient profiling.

Neuromorphic Technology​

• Efficient pattern recognition for subtle disease indicators.
• Event-driven processing for real-time detection. This is crucial for detecting anomalies or irregularities that may be early signs of diseases.
• Continuous monitoring for dynamic changes. This continuous surveillance is especially valuable for conditions with varying symptoms.

Diagnosis​

Multimodal AI​

• Integrated diagnostic insights from diverse data.
• Cross-verification for reliability.
• Tailored treatment plans based on nuanced understanding.
• Continuous updates based on latest findings reported in the subject.

Neuromorphic Technology​

• Large and Efficient data processing with minimal energy consumption. This efficiency contributes to faster and more accurate diagnoses.
• Allows integration of more complex algorithms on wearable devices; makes diagnostics more real-time and helps timely interventions
• Implantable devices can be made AI enabled with Neuromorphic computing, due to the low computing requirement and power consumption, making the diagnosis and management more precise and real-time.
• Adaptive intelligence for dynamic adjustments. This adaptability enhances the precision of diagnostic processes. This event-driven processing aligns with the dynamic nature of healthcare data allowing for more accurate and timely diagnoses.
• SNN for real-time response
  and accuracy.

Prognosis​

Multimodal AI​

• Research Advancements: Facilitates discovery of new insights, contributing to medical advancements and innovations.
• Personalised Prognostic Models: Considering both visual and clinical data, these models account for individual variations, and correlate with prior case records and provide more accurate predictions of disease outcomes.
• Dynamic Adaptability: The adaptability of multimodal AI to changing data patterns ensures that prognostic models can dynamically adjust based on evolving patient conditions and improve prognosis predictions

Neuromorphic Technology​

• Analysis of longitudinal data for predicting disease progression.
• Dynamic adaptability in prognostic models that can adjust to changing data patterns. This adaptability improves prognosis prediction accuracy for evolving patient conditions.
• Personalised prognostic insights based on individual variations can help in more accurate predictions tailored to individual patient profiles.

Tata Elxsi Use Case​

Disease Detection and Diagnosis​

Utilising Neuromorphic Technology, we’ve achieved significant advancements in the analysis of medical images on low-computing embedded platforms, enabling on-field diagnostics of ultrasound images.
This innovative approach provides critical diagnostic information for musculoskeletal injuries, including tissue damage extent, recovery progress, and healing time predictions, all with enhanced efficiency and device portability making it ideal for applications such as sports medicine.

Applications of Multimodal and Neuromorphic AI​

Multimodal AI​

• Comprehensive Patient Analysis
• Diagnostic Accuracy
• Mental Health and Behavioural Analysis
• Lifestyle Reviews and Recommendations
• Management of Chronic Diseases like Diabetes/HT/Cardiac Diseases with continous monitoring and personalised medications
• Diagnosis/Management and Prognosis of various types of cancers, Digital Drug Trials, Effective Pandemic Surveillance and staging, Gene Therapy and Genomics
• Recommendations for interventions and Prioritisation of therapeutic resources and modalities

Neuromorphic Technology​

• Implants, Wearables Devices
• Processing Large Data
• Medical Imaging Analysis
• Drug Discovery and Personalised Medicine
• Robotic Surgery Assistance
• Neurological Disorder Understanding
• Patient Care and Rehabilitation
• Predictive Analytics for Healthcare Management
• Energy Efficient Remote Monitoring

The Synergy of MLOps and Advanced AI​

The transformative impact of MLOps across operational efficiency, data management, patient outcomes, and the overall quality of care is unmistakable. In the quest for advancing healthcare, the convergence of Machine Learning Operations (MLOps) with Multimodal and Neuromorphic AI has emerged as a game-changer. These technologies can help in seamless deployment, continuous monitoring, and collaborative development across various stakeholders in the healthcare ecosystem.
While Advanced AI Technologies offer the potential for improvising the use cases, the application of MLOps can be instrumental in strengthening and regulating these advancements. It achieves this by bringing in streamlined AI development processes, dataset management, continuous monitoring of model accuracy across different versions, ensuring the deployment of thoroughly vetted versions for clinical use. Additonally, MLOps frameworks enable and learn from deviations, further enhancing their efficacy in healthcare applications.

Use Cases​

Disease Detection​

Disease Prediction and Prevention
Real World Application – Early Detection of Chronic Disease, Infectious Disease Monitoring
Healthcare Fraud Detection
Real World Application – Claims Analysis, Identify Theft Prevention
Medical Imaging Analysis
Real World Application – Early Cancer Detection, Neurological Disorders Diagnosis
Genomic Research
Real World Application – Cancer Genomics, Rare Genetic Diseases

Diagnosis​

Drug Discovery and Development
Real World Application – Protein Folding Prediction, Drug Toxicity Prediction
Personalised Medicine
Real World Application – Oncology and Targeted Therapies, Chronic Disease Management
Healthcare Resource Management
Real World Application – Emergency Room Digitalised Management, Pharmaceutical Supply Chain Management

Prognosis​

Prediction of Clinical Outcome
Real World Application – Prediction of recovery time and quality of life, Adverse Effects, Short term and long term impact
Remote Patient Monitoring
Real World Application – Chronic Disease Management, Post Surgery Monitoring

Responsible AI – Navigating Ethical Frontiers​

In the realm of AI, addressing bias stands as a pivotal ethical imperative, particularly in fields like medical analysis where the demand for precision is ethically, legally, and morally paramount. As AI practitioners, our commitment to responsible AI requires rigorous testing using diverse, unbiased anonymised datasets, continual monitoring to mitigate biases, and a steadfast dedication to achieving fair outcomes across diverse patient populations.

Moreover, the ethical considerations extend to the strategic utilisation of data. The foundation of responsible AI in healthcare is laid upon a robust ethical framework that guides the entire lifecycle of Neuromorphic and Multimodal AI systems. Stakeholders must unwaveringly adhere to established ethical principles, ensuring transparency, fairness, and accountability at every stage of AI implementation.
When we delve into the realm of Gen AI, the potential for malpractice looms. Consider scenarios where a patient, with normal renal function manageable through medication, undergoes a renal scan. Unscrupulous use of Gen AI could manipulate images, creating false lesions, leading to unnecessary surgeries or even nephrectomy which can benefit illegal organ trade
Thus, the imperative lies in defining strong ethical boundaries, implementing robust audits, and establishing legal frameworks to prevent data manipulation and ensure the highest standards of integrity.
In embracing these technological advancements responsibly, we are not just witnessing the future of healthcare; we are actively shaping it. The era of proactive, preventive healthcare beckons, promising a future where wellness is at the forefront of the industry’s evolution.
The shift from traditional, one-size-fits-all medical practices, prone to misinterpretation and diagnostic errors, to AI-enhanced methodologies, heralds a new era of precision and personalised care. AI’s capability to analyse a broad spectrum of patient data—ranging from genetic backgrounds to lifestyle factors—promises a departure from misdiagnoses and introduces tailored therapeutic interventions.
AI and multimodal technologies enable a holistic view of the patient’s health, integrating diverse data points. While, Neuromorphic computing advances the portability of medical devices, including wearables and implants, transforming them into intelligent systems capable of adapting to varying conditions.
As thought leaders in the healthcare industry, our commitment to responsibly integrate these technologies paves the way for a future where healthcare is not only reactive, but anticipatory, personalised, and universally accessible.

Author

Anup S S
Practice Head, Artificial Intelligence, Tata Elxsi
Anup S.S. is a visionary in leveraging Artificial Intelligence, Machine Learning and Deep Learning. Leading breakthrough AI projects in healthcare, Anup’s strategic insight and innovation ignite client success, unlocking AI’s full potential.

FMF...thanks, that is another top class report you have posted....it's pretty clear to me at least that our relationship with TATA in general
has and continues to blossom...I still think they (TATA) will be our next IP signing, combined with our IP TATA is destined to become an
even bigger giant than they already are, worldwide.

Regards...Tech

 

[Tezza]

Quarterly after hours today as asx closed tomorrow, or Friday after hours?

 

[DK6161]

Quarterly after hours today as asx closed tomorrow, or Friday after hours?

First thing this morning please. Put me out of my misery

 

[TECH]

I am not sure if Dio or someone has posted this, but this TATA Patent was only published 7/8 days ago...it looks very promising.

Espacenet – search results

Espacenet: free access to millions of patent documents. Find out if your invention is unique or if other inventors have filed patent applications that are considered to be prior art.

worldwide.espacenet.com

Regards.....Tech

 

[Esq.111]

Morning Tech ,

Nice find .

Extract..

[0079] The active power consumption of a neuromorphic hardware is mainly contributed by the spiking network's total number of synaptic operations (SOP). Following (7) and the method mentioned in Sorbaro et al. (e.g., refer “Martino Sorbaro, Qian Liu, Massimo Bortone, and Sadique Sheik, “Optimizing the energy consumption of spiking neural networks for neuromorphic applications,” Frontiers in Neuroscience, vol. 14, pp. 662, 2020.”), total number of synaptic operation for the SNN of the system 100 is found to be ˜35M while that for the CNN is ˜95M (considering matrix multiplication only). This converted SNN can be implemented on neuromorphic platforms such as Brainchip Akida (e.g., refer “Brainchip unveils the akidatm development environment,” https://www.brainchipinc.com/news-m...chip-unveils-the-akida-developmentenvironment, 2019”), Intel® Loihi (e.g., refer “Mike Davies. et. al, “Advancing neuromorphic computing with loihi: A survey of results and outlook,” Proceedings of the IEEE, vol. 109, no. 5, pp. 911-934, 2021.”), etc. to achieve further power benefit (˜100×). FIG. 9 shows the confusion matrix for converted SNN for 8 gesture classes. More specifically, FIG. 9 , with reference to FIGS. 1 through 8 , depicts a confusion matrix for Gest-SNN dataset (SNN dataset as used by the present disclosure), in accordance with an embodiment of the present disclosure. Though most of the classes are correctly classified, Click and Double Click being single point gestures, are sometimes confused by the network. Also, the mean value of the class wise Average Precision (AP) is found to be 0.9425 and mean of Average Recall (AR) is found to be 0.9400 for the SNN of the system 100 .

https://v.ftcdn.net/02/78/46/33/700_F_278463314_sxUpEvx7rkbtZzofiJH6QUTYIgDkyuTh_ST.mp4

Regards ,
Esq.

 

[Damo4]

I am not sure if Dio or someone has posted this, but this TATA Patent was only published 7/8 days ago...it looks very promising.

Espacenet – search results

Espacenet: free access to millions of patent documents. Find out if your invention is unique or if other inventors have filed patent applications that are considered to be prior art.

worldwide.espacenet.com

Regards.....Tech

Great find Tech, very very promising!

Acoustic system and method based gesture detection using spiking neural networks​

Abstract​

Conventional gesture detection approaches demand large memory and computation power to run efficiently, thus limiting their use in power and memory constrained edge devices. Present application/disclosure provides a Spiking Neural Network based system which is a robust low power edge compatible ultrasound-based gesture detection system. The system uses a plurality of speakers and microphones that mimics a Multi Input Multi Output (MIMO) setup thus providing requisite diversity to effectively address fading. The system also makes use of distinctive Channel Impulse Response (CIR) estimated by imposing sparsity prior for robust gesture detection. A multi-layer Convolutional Neural Network (CNN) has been trained on these distinctive CIR images and the trained CNN model is converted into an equivalent Spiking Neural Network (SNN) via an ANN (Artificial Neural Network)-to-SNN conversion mechanism. The SNN is further configured to detect/classify gestures performed by user(s).

 

[Newk R]

I am not sure if Dio or someone has posted this, but this TATA Patent was only published 7/8 days ago...it looks very promising.

Espacenet – search results

Espacenet: free access to millions of patent documents. Find out if your invention is unique or if other inventors have filed patent applications that are considered to be prior art.

worldwide.espacenet.com

Regards.....Tech

I have read the patent and this bit concerned me.

𝑋𝑖=(𝑥𝑖(0)𝑥1(-1)…𝑥𝑖(-𝐿+1)𝑥𝑖(1)𝑥𝑖(0)…𝑥𝑖(-𝐿+2)⋮⋮⋱⋮𝑥𝑖(𝑃-1)𝑥𝑖(𝑃-2)…𝑥𝑖(𝑃-𝐿))(3)

But after careful consideration I now agree.

 

[HopalongPetrovski]

I have read the patent and this bit concerned me.

𝑋𝑖=(𝑥𝑖(0)𝑥1(-1)…𝑥𝑖(-𝐿+1)𝑥𝑖(1)𝑥𝑖(0)…𝑥𝑖(-𝐿+2)⋮⋮⋱⋮𝑥𝑖(𝑃-1)𝑥𝑖(𝑃-2)…𝑥𝑖(𝑃-𝐿))(3)

But after careful consideration I now agree.

It all comes together once you simply add Pi.

 

[MegaportX]

Quarterly after hours today as asx closed tomorrow, or Friday after hours?

Quarterly after hours today as asx closed tomorrow, or Friday after hours?

I hope not that is never a good look. I am assuming Next Monday or Tuesday. Team is very busy this week by accounts.
I am thinking we will see some improvement in revenue, but I am wondering if it will be enough to satisfy Mr Market.
We shall see soon..


MegaportX

 

[Diogenese]

I am not sure if Dio or someone has posted this, but this TATA Patent was only published 7/8 days ago...it looks very promising.

Espacenet – search results

Espacenet: free access to millions of patent documents. Find out if your invention is unique or if other inventors have filed patent applications that are considered to be prior art.

worldwide.espacenet.com

Regards.....Tech

Hi Tech,

Yes, the CNN-to-SNN conversion is particularly telling:

Conventional gesture detection approaches demand large memory and computation power to run efficiently, thus limiting their use in power and memory constrained edge devices. Present application/disclosure provides a Spiking Neural Network based system which is a robust low power edge compatible ultrasound-based gesture detection system. The system uses a plurality of speakers and microphones that mimics a Multi Input Multi Output (MIMO) setup thus providing requisite diversity to effectively address fading. The system also makes use of distinctive Channel Impulse Response (CIR) estimated by imposing sparsity prior for robust gesture detection. A multi-layer Convolutional Neural Network (CNN) has been trained on these distinctive CIR images and the trained CNN model is converted into an equivalent Spiking Neural Network (SNN) via an ANN (Artificial Neural Network)-to-SNN conversion mechanism. The SNN is further configured to detect/classify gestures performed by user(s).

 

[keyeat]

Nintendo Live 2024 Sydney

www.nintendo.com.au

I wonder why its in Australia ....

 

[DingoBorat]

View attachment 61438

Nintendo Live 2024 Sydney

www.nintendo.com.au

I wonder why its in Australia ....

I'd be very surprised, if we weren't incorporated into a Nintendo product, very soon.

The obvious contender is the Switch 2.

Like everything else, the release date has been continually pushed out..

Nintendo Switch 2: Rumored Release Date, Rumors, Specs, & More

Nintendo is probably gearing up to announce its next console--here's what we know so far.

www.gamespot.com

This Nintendo Live event, will most likely contain the actual release date, which currently stands as early 2025.

 

[Adam]

Quarterly after hours today as asx closed tomorrow, or Friday after hours?

Ir? Last thing on the mind. Watch the financials..join the dots..let's release the results as late as possible. Standard operation procedure. (sic).
Brn management..listen to the feedback of the long term holders, perchance. Tell us what you can, ndas aside.Maybe, a lesson to be learned, instead of sating the shorters, bots and 2 cent holders on this forum. Please, take heed. We have been faithfull for a decade, maybe..listen to us. Also..proper links, no ref to podcasts, and straight, market updates, no linkedin links, etc. That would appease us all. Im tired of hockey sticks and hollow promises. Members of the board - take stock and own.. your duty ..as members of the BOARD, to us, the shareholders. Notifications please, for better or worse. I don't want to read about Tesla.Apple..etc. etc, maybe.being in bed with us. Share info, where you legally can. TY for listening to us long term holders who believe in the product.

 

[DK6161]

I'd be very surprised, if we weren't incorporated into a Nintendo product, very soon.

The obvious contender is the Switch 2.

Like everything else, the release date has been continually pushed out..

Nintendo Switch 2: Rumored Release Date, Rumors, Specs, & More

Nintendo is probably gearing up to announce its next console--here's what we know so far.

www.gamespot.com

This Nintendo Live event, will most likely contain the actual release date, which currently stands as early 2025.

Yep. Per last year event, this will just showcase new upcoming game releases. People go there to try out new games

 

[DingoBorat]

Yep. Per last year event, this will just showcase new upcoming game releases. People go there to try out new games

Always with da negative waves

 

[Makeme 2020]

FMF...thanks, that is another top class report you have posted....it's pretty clear to me at least that our relationship with TATA in general
has and continues to blossom...I still think they (TATA) will be our next IP signing, combined with our IP TATA is destined to become an
even bigger giant than they already are, worldwide.

Regards...Tech

When 2030

 

[SharesForBrekky]

For anyone interested:

Begin Registration

events.arm.com

Building Edge AI using Arm, NVIDIA, and Edge Impulse

Join us for our Arm Tech Talk on April 30th at 4pm BST/8am PT for a deep dive into the latest edge AI integration powered by Arm, NVIDIA, and Edge Impulse. In this talk, we will explore a computer vision use case for industrial asset tracking, specifically pallet counting. From generating synthetic data to building new ML models to deploying onto edge devices, we will cover the solution from end to end. This session will show the paved path to use Edge Impulse along with NVIDIA Omniverse and TAO to deploy industrial-grade AI models onto Arm-based devices.